Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India · Delayed Price · Currency is INR 815.80
-2.70 (-0.33%)
Oct 1, 2026, 3:30 PM IST
NSE:AKUMS Market Cap
NSE:AKUMS has a market cap or net worth of 124.49 billion as of October 1, 2026. Its market cap has increased by 84.19% in one year.
Market Cap
124.49B
Enterprise Value
109.78B
Revenue
45.04B
Ranking
n/a
PE Ratio
42.69
Stock Price
815.80
ChartMarket Cap Chart
Since August 6, 2024, NSE:AKUMS's market cap has decreased from 125.32B to 124.49B, a decrease of -0.67%. That is a compound annual growth rate of -0.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 124.49B | 79.33% |
| Dec 31, 2025 | 69.42B | -30.92% |
| Dec 31, 2024 | 100.48B | -19.82% |
| Aug 6, 2024 | 125.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 274.52B |
| Cohance Lifesciences | 169.86B |
| Alivus Life Sciences | 169.29B |
| Eris Lifesciences | 165.36B |
| Alembic Pharmaceuticals | 162.25B |
| NATCO Pharma | 148.21B |
| Sudeep Pharma | 136.19B |
| Strides Pharma Science | 103.23B |